← Open Payments lookup

LUIS FEBUS: Open Payments

NPI 1407026248 · EDGEWATER, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$995 in 57 payments from 8 companies in 2025. Trend: 2023 $752 · 2024 $1,166 · 2025 $995

Food & beverage: $995
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.15$311
ABBVIE INC.16$266
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$175
Teva Pharmaceuticals USA, Inc.5$83
Takeda Pharmaceuticals U.S.A., Inc.4$65
Almatica Pharma LLC3$48
Supernus Pharmaceuticals, Inc.2$29
E.R. Squibb & Sons, L.L.C.1$17

Products named: VRAYLAR, REXULTI, CAPLYTA, ABILIFY MAINTENA, UZEDY, TRINTELLIX, LOREEV XR, Qelbree.

Industry payments across NJ — which companies pay providers there.